Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project : New Drugs of AbuseDELUCA, Paolo; DAVEY, Zoe; PEZZOLESI, Cinzia et al.Progress in neuro-psychopharmacology & biological psychiatry. 2012, Vol 39, Num 2, pp 221-226, issn 0278-5846, 6 p.Article

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine AdministrationKOLBRICH, Erin A; GOODWIN, Robert S; GORELICK, David A et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 4, pp 432-440, issn 0271-0749, 9 p.Article

Gamma-hydroxybutyrate and ethanol effects and interactions in humansTHAI, Dung; DYER, Jo Ellen; BENOWITZ, Neal L et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 5, pp 524-529, issn 0271-0749, 6 p.Article

Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity : New Drugs of AbuseWOOD, David M; DARGAN, Paul I.Progress in neuro-psychopharmacology & biological psychiatry. 2012, Vol 39, Num 2, pp 227-233, issn 0278-5846, 7 p.Article

Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabisRUBIO, Gabriel; MARIN-LOZANO, Jesús; LOPEZ-TRABADA, Jose Ramon et al.Comprehensive psychiatry (Print). 2012, Vol 53, Num 8, pp 1063-1070, issn 0010-440X, 8 p.Article

Gamma-butyrolactone (GBL) dependence and withdrawalBELL, James; COLLINS, Rodney.Addiction (Abingdon. Print). 2011, Vol 106, Num 2, pp 442-447, issn 0965-2140, 6 p.Article

The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in HumansO'MATHUNA, Brian; FARRE, Magi; DE LA TORRE, Rafael et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 5, pp 525-531, issn 0271-0749, 7 p.Article

ECSTASY ANALOGUES FOUND IN CACTIBRUHN, Jan G; EL-SEEDI, Hesham R; STEPHANSON, Nikolai et al.Journal of psychoactive drugs. 2008, Vol 40, Num 2, pp 219-222, issn 0279-1072, 4 p.Article

Reasoning deficits in ecstasy (MDMA) polydrug usersFISK, John E; MONTGOMERY, Catharine; WAREING, Michelle et al.Psychopharmacologia. 2005, Vol 181, Num 3, pp 550-559, issn 0033-3158, 10 p.Article

Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis UsersHENRY, Erika A; KAYE, Jesse T; BRYAN, Angela D et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 5, pp 1214-1221, issn 0893-133X, 8 p.Article

Cannabis et schizophrénieCOSTENTIN, J.L' Encéphale (Paris). 2013, Vol 39, pp 21-22, issn 0013-7006, 2 p., HS1Conference Paper

Dose-response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sampleRUIZ-VEGUILLA, Miguel; LUISA BARRIGON, María; HERNANDEZ, Laureano et al.Journal of psychiatric research. 2013, Vol 47, Num 8, pp 1036-1043, issn 0022-3956, 8 p.Article

Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiologyDUMONT, Gjh; KRAMERS, C; SWEEP, Fcgj et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 2, pp 165-174, issn 0269-8811, 10 p.Article

L'exploit des corps en « ecstase » = The exploit of the bodies in ecstasyFONSECA ZAS, Maria Vanina.Champ psychosomatique (Grenoble). 2008, Num 51, pp 165-175, issn 1266-5371, 11 p.Article

Users' perceptions of the risks and effects of taking ecstasy (MDMA) : a questionnaire studyMURPHY, Philip N; WAREING, Michelle; FISK, John E et al.Journal of psychopharmacology (Oxford). 2006, Vol 20, Num 3, pp 447-455, issn 0269-8811, 9 p.Conference Paper

Subacute effects of ecstasy on mood: an exploration of associated risk factorsSCOTT, Rebecca M; HIDES, Leanne; ALLEN, J. Sabura et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 1, pp 53-61, issn 0269-8811, 9 p.Article

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effectsCAUDEVILLA-GALLIGO, Fernando; RIBA, Jordi; VENTURA, Mireia et al.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 7, pp 1026-1035, issn 0269-8811, 10 p.Article

Antagonist-Elicited Cannabis Withdrawal in HumansGORELICK, David A; GOODWIN, Robert S; HUESTIS, Marilyn A et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 5, pp 603-612, issn 0271-0749, 10 p.Article

Cannabis use and psychosis: re-visiting the role of childhood traumaHOUSTON, J. E; MURPHY, J; SHEVLIN, M et al.Psychological medicine (Print). 2011, Vol 41, Num 11, pp 2339-2348, issn 0033-2917, 10 p.Article

Intelligence and past use of recreational drugsWILMOTH, Daniel R.Intelligence (Norwood). 2012, Vol 40, Num 1, pp 15-22, issn 0160-2896, 8 p.Article

Effects of MDMA on sociability and neural response to social threat and social rewardBEDI, Gillinder; LUAN PHAN, K; ANGSTADT, Mike et al.Psychopharmacologia. 2009, Vol 207, Num 1, pp 73-83, issn 0033-3158, 11 p.Article

Disrupted Gamma-Band Neural Oscillations During Coherent Motion Perception in Heavy Cannabis UsersSKOSNIK, Patrick D; KRISHNAN, Giri P; D'SOUZA, Deepak C et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 13, pp 3087-3099, issn 0893-133X, 13 p.Article

Lhermitte's sign, electric shock sensations and high dose ecstasy consumption: preliminary findingsBOLAND, B; MITCHESON, L; WOLFF, K et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 2, pp 213-220, issn 0269-8811, 8 p.Article

Severe Ecstasy poisoning in an 8-month-old infantEIFINGER, Frank; ROTH, Bernhard; KRÖNER, Lars et al.European journal of pediatrics. 2008, Vol 167, Num 9, pp 1067-1070, issn 0340-6199, 4 p.Article

Problematic versus non-problematic ecstasy/MDMA use : the influence of drug usage patterns and pre-existing psychiatric factorsSOAR, K; TURNER, J. J. D; PARROTT, A. C et al.Journal of psychopharmacology (Oxford). 2006, Vol 20, Num 3, pp 417-424, issn 0269-8811, 8 p.Conference Paper